Bayesian Health vs MyoVista wavECG

According to Bayesian Health's September announcement, Medicare's new technology add-on payment covers up to $61.84 per eligible fee-for-service inpatient case for up to three years from October 1, 2026. That payment goes to the hospital and is not Bayesian's fee, which is not public. The FDA cleared the sepsis flagging software behind it as K250680 on April 30, 2026. It reads EHR data continuously and shows a Sepsis Risk High flag in the chart for adults, and a hospital sepsis program is the buyer. A sepsis flag and an ECG product serve unrelated clinical problems. HeartSciences calls itself a healthcare information technology company focused on electrocardiography, and its site says its AI-ECG products are in development and not commercially available in the United States. Its wavECG, cleared in October 2026, carries no AI algorithm. The vendor aims MyoVista Insights at sites that gather 12-lead tracings from several devices.